黑色素对2型糖尿病血糖变量的影响:交叉,双盲,安慰剂控制试验的协议
Wagner Martorina1, Almir Tavares1,2
1Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Brazil.
JMIR research protocols
|July 6, 2023
概括
补充メラトニン可以降低2型糖尿病的血糖波动. 这项研究调查了黑激素.
科学领域:
- 内分泌学和新陈代谢学
- 时间生物学 时间生物学
- 糖尿病研究研究 糖尿病研究
背景情况:
- 血糖的变化是2型糖尿病 (T2DM) 的微和宏血管并发症的一个关键因素.
- 调节昼夜节律和葡萄糖代谢的荷尔蒙 - - 黑色素 (melatonin) 在T2DM患者中往往缺乏.
- 研究黑激素替代剂对于了解其在T2DM中改善血糖控制的潜力至关重要.
研究的目的:
- 评估T2DM患者的黑激素替代治疗是否可以改善黑激素缺乏症的胰岛素分泌节律和敏感性.
- 为了确定黑激素对降低2型糖尿病血糖变异性的作用.
- 探索一种用于管理T2DM并发症的新型治疗策略.
主要方法:
- 一个随机,双盲,安慰剂控制的交叉试验,涉及30名T2DM患者.
- 参与者每晚接受3毫克的黑激素或安慰剂,持续一周,然后是洗期,然后是替代治疗.
- 每个治疗周的最后三天,每天测量六次毛细血管血糖水平.
主要成果:
- 在2023年3月至4月期间,30名T2DM个人招募参与者并完成研究.
- 这项研究预计将观察到黑色素和安慰剂治疗日之间的差异性血糖变化.
- 现有文献对黑激素对血糖控制的影响提出了不同的结论,强调了这项研究的具体结果的必要性.
结论:
- 这项研究旨在验证黑激素补充作为一种有效的方法,以减少T2DM的血糖变化.
- 交叉设计可以解释混的昼夜变量,如饮食,活动和睡眠.
- 鉴于黑激素的低成本和减轻严重T2DM并发症的潜在益处,这项研究至关重要,特别是考虑到其广泛使用.
关键词:
这就是T2DM.昼夜节律 昼夜节律交叉研究是交叉研究.葡萄糖 葡萄糖 葡萄糖 是 一种血糖控制 血糖控制 血糖控制血糖的变异性 血糖的变异性黑激素是什么意思 黑激素是什么意思随机对照试验是随机对照试验.2型糖尿病是什么?更多相关视频
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
312
06:13Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
Published on: December 1, 2023
1.2K
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Oral Hypoglycemic Agents: Biguanides and Glitazones
238
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
238
Diabetes Mellitus: Overview and Type I Subtype
2.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Management of Insomnia
281
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
281
Hormones Regulating Blood Glucose
3.6K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.6K
Diabetes: Management and Pharmacotherapy
319
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
319
